Kejako is developing new solutions to cure presbyopia, an age age-related farsightedness. The startup has completed a seed round of CHF 770’000 to fund the development of its technology.
Kejako SA is developing minimally invasive surgical solutions for patients affected by Presbyopia, a progressive old age vision disorder that causes difficulty to focus clearly on nearby objects. Unlike existing solutions such as reading glasses, contact lenses and progressive spectacles, Kejako’s solutions address the root cause of presbyopia with a breakthrough approach, combining simulation and minimally invasive treatment.
The Genève based startup built the first and proprietary full eye 3D parametric model combined with multi-physics numerical modeling to compute the full eye’s normal optical and mechanical behavior, as well as the resulting impacts due to a specific eye disease. It optimizes each patient’s treatment, enabling patients to plan and control the corresponding customized procedure. The model has already been calibrated for the visual accommodation analysis and presbyopia simulation. Other applications are underway.
Additionally, through the power of its parametric eye model, Kejako is also offering a non-Invasive treatment for the restoration of the visual accommodation amplitude through the application of a specific spatial pattern and appropriate settings of laser energy, which are customized for each patient. Consequently, this will induce new optical and mechanical properties in the lens to restore natural lens functions, without inducing cataracts, to provide enough effective dynamic visual accommodation unlike existing basic optical static correction.
The startup has now raised CHF 770’000 in seed financing round from BAS members and alongside Fongit Seed Invest (FSI) and other angel investors. Kejako will use the funds to accelerate the development of its technology.
(ran)
Please login or sign up to comment.
Commenting guidelines